---
$id: https://graph.org.ai/products/commodity/51143011
$type: Product
source: UNSPSC
code: "51143011"
title: "Vinconate"
class: "51143000"
classTitle: "Nootropics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vinconate

**UNSPSC Code**: 51143011
**Class**: [Nootropics](Nootropics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cholinergic agonist with the molecular formula C18H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 807MP0MJ61, chemically known as 1h-indolo(3,2,1-de)(1,5)naphthyridine-6-carboxylic acid, 3-ethyl-2,3,3a,4-tetrahydro-, methyl ester, (+-)- but generally known as vinconate, which bears US NIH Compound Identifier 68896. European Medicines Agency schedules Vinconate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00058MIG. The term VINCONATE is an International Non-Proprietary Name. VINCONATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vinconate under HS 29339990 and SITC 51577. As of Q4 2014, VINCONATE remains the US FDA Preferred Term for this commodity. Vinconate bears US NLM identifiers UMLS ID C0078247 and NCI Concept Code C76615. SMILES: O(C(=O)C1=CCC2N(CCC3C2N1C1C3CCCC1)CC)C.

